Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. - Wikidata - awgldk - TriplyDB

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

http://www.wikidata.org/entity/Q36573399

about

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma Asthma, nasal polyposis and ulcerative colitis: a new perspective Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma.Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Alternative strategies in the treatment of bronchial asthma.Treatment of aspirin-intolerant asthma with antileukotrienes.The aspirin disease Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field.Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study Aspirin-exacerbated respiratory disease and current treatment modalities.Anti-leukotriene agents: a new direction in asthma therapy.Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors The investigation into indomethacin-induced potentiation of the contractile response to antigen in ovalbumin-sensitized guinea-pig tracheas.Arachidonic Acid Metabolism in Nasal Tissue and Peripheral Blood Cells in Aspirin Intolerant Asthmatics

P2860

Q24564777-6331AE0E-9D9C-45AD-8A8C-B68BA80E1A14 Q28193641-46937312-6BDB-4B37-8727-912D6E7ACD01 Q28193652-D1AE32CC-C2E5-4B37-8891-E3F77ED21774 Q28194198-400F1196-2C6C-4A53-AC50-B1ACF8A402DF Q33593217-FC7F8AD0-1DCE-485D-8EDC-4A457D8B945E Q33595339-0F7FE024-021B-48B1-ABEB-BF3CCCB58855 Q33801225-E2FFC057-EF65-497F-9C2C-AB9BF9BE59B7 Q33836771-48208CB9-B582-4BF6-927E-9E2DBB918083 Q35577349-428D9141-66E5-4689-9105-6AE0AA3A132A Q36505616-AE6224C5-1EF5-47E6-AA42-B61F6A226906 Q37016080-C644FD5F-9990-4F15-B36F-0B89A2C92924 Q37391120-BBA36E4A-2DBC-42DC-B5C3-2EE628EBE0EC Q38931124-D3D53389-4EBB-4375-8D00-3F1C03EAE2BB Q41270730-790F5D16-CFBA-4F48-82C3-CF64E794A061 Q42541810-106E772F-33E4-495B-8779-EADDADD8D41D Q46230182-71072501-A073-4C69-B788-56EB69ABE28E Q58279309-00E06B1C-7BD5-40E9-9FD7-601CC19B4EFF

P2860

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

http://www.wikidata.org/entity/Q36573399

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@ast

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@en

type

label

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@ast

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@en

prefLabel

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@ast

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@en

P1433

Q36573399-86EC5CB3-4999-4D95-A5DD-44E4E0299C5D

P1476

Q36573399-530D557B-4F96-4B1A-9BD9-080BF2C0C9E9

P2093

Q36573399-2404D745-8D38-4B26-8459-E2DE9280888D

Q36573399-7FFBC7E3-42F3-4651-915D-166693193C82

Q36573399-8C7942BE-750E-441A-A4CC-6410E5DC6C9D

Q36573399-A1A8C8D0-7C14-40DB-9FEC-D810049F2469

Q36573399-B48924DC-3A18-419C-9623-411A1A59601D

Q36573399-D2E31D4D-131C-4E95-BFFF-3750ED8F3925

Q36573399-D3E59FB5-7441-4527-90A3-9C63E25245C1

Q36573399-E17544CC-A056-478D-8B98-CD431AA45236

P2860

Q36573399-095A1F45-A7CA-49AE-BCF1-6ABDA0A67662

Q36573399-1970DE8D-DB46-40FB-8A36-4A352CD35560

Q36573399-1A9C80F5-5757-4A2E-8C75-6D11B434F713

Q36573399-33FB4E7B-139C-4E83-BEBB-B86826BA2D65

Q36573399-3A24272A-CAF0-454C-9323-631BFDE3AD43

Q36573399-65F4EEC6-8D7B-4334-9AA8-0FFCC13CDC83

Q36573399-774FFF7B-D591-4E36-BCE0-E383D1E82634

Q36573399-7BC98C62-81DE-46FB-9409-9E18F7EBA3AE

Q36573399-86842DEB-4F9E-4705-A8C3-F6391B89BA8B

Q36573399-9C08B041-0ACD-4D29-8D45-700B6B925F74

P304

Q36573399-C41D1F82-6B16-4FAE-9ECD-20057928D614

P31

Q36573399-670915F4-95A8-49A7-8413-6433D560E6BB

P356

Q36573399-FB57DF14-9B57-4569-9D6E-32965C4411CC

P407

Q36573399-8216EF38-1759-4F5F-A78B-68A4466CAE47

P433

Q36573399-35C4D07E-ABE1-477B-9138-AD926DD23B36

P478

Q36573399-86D135D9-8704-41E4-A9C6-C940FA29A243

P577

Q36573399-B5110E78-8400-4935-9392-60F83FAB7ABB

P5875

Q36573399-91E40818-6DF4-4167-8A67-79906DF0472D

P698

Q36573399-AB75E236-0AD1-4878-AA99-DE9D941BA957

P921

Q36573399-81D5AC0D-4FCA-4CA4-A607-ECBF6892E739

Q36573399-86523694-DE23-48AC-BB86-68066C9697C8

P932

Q36573399-C802AE60-0CF2-4A12-937F-2E42A71C0215

P356

P1433

P1476

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

@en

P2093

Arm JP

http://www.w3.org/2001/XMLSchema#string

Bell GS

http://www.w3.org/2001/XMLSchema#string

Foster S

http://www.w3.org/2001/XMLSchema#string

Lee TH

http://www.w3.org/2001/XMLSchema#string

MacMillan R

http://www.w3.org/2001/XMLSchema#string

Nasser SM

http://www.w3.org/2001/XMLSchema#string

Spruce KE

http://www.w3.org/2001/XMLSchema#string

Williams AJ

http://www.w3.org/2001/XMLSchema#string

P2860

Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Solubilization and characterization of the leukotriene C4 synthetase of rat basophil leukemia cells: a novel, particulate glutathione S-transferase.

Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro.

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

Increased excretion of leukotriene E4 during aspirin-induced asthma.

P304

749-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.49.8.749

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15108569

http://www.w3.org/2001/XMLSchema#string

P698

8091318

http://www.w3.org/2001/XMLSchema#string

P921

P932

475118

http://www.w3.org/2001/XMLSchema#string